← Evidence map

ReviewDrug safety1998

A risk-benefit assessment of epoetin in the management of anaemia associated with cancer.

Y BeguinPubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

this paperpooled itcites it

A risk-benefit assessment of epoetin in the management of anaemia associated with cancer. | OpenQuestion